Paul Chew

Chief Medical Officer at Phesi

Paul Chew is a board-certified cardiologist and internist, serving most recently as Chief Medical Officer for Omada Health, a Silicon Valley-based digital therapeutics company aimed at preventing chronic disease. At Omada, Dr. Chew and his team launched the largest randomized clinical trial in digital therapeutics. Dr. Chew has also held several leadership positions at major pharmaceutical companies. At Sanofi, he served as Senior Vice-President, Global Chief Medical Officer in Paris, and U.S. R&D Head, and at Bristol-Myers Squibb he led the clinical launch of Glucophage® (metformin) in the U.S. and Europe. Dr. Chew is currently on the Board of Trustees for the U.S. Pharmacopeial Convention, which develops and publishes quality standards for drug substances, drug products, excipients, and dietary supplements in the USP–National Formulary (USP–NF), and is recognized by the FDA and 140 countries around the world. Dr. Chew spent 22 years at Johns Hopkins where he received his undergraduate and medical education, served his Osler medical residency, and was a member of the interventional cardiology faculty, holding joint faculty appointments in Radiology and Cardiology.

Links


Org chart

Sign up to view 0 direct reports

Get started